BDBM50317098 1-(1-{(2S)-3-[(6-chloronaphthalen-2-yl)sulfonyl]-2-hydroxypropanoyl}piperidin-4-yl)tetrahydropyrimidin-2(1H)-one::CHEMBL1095032::TAK-442

SMILES c1cc(cc2c1cc(cc2)Cl)S(=O)(=O)C[C@H](C(=O)N3CCC(CC3)N4CCCNC4=O)O

InChI Key InChIKey=GEHAEMCVKDPMKO-UHFFFAOYSA-N

Data  1 KI  7 IC50

PDB links: 1 PDB ID matches this monomer.

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 50317098   

TargetCoagulation factor X(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50317098(TAK-442 | 1-(1-{(2S)-3-[(6-chloronaphthalen-2-yl)s...)
Affinity DataIC50: 3.5nMAssay Description:Inhibition of human factor 10a assessed as p-nitroanilide release using S2765 as substrate by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2010
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetProthrombin(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50317098(TAK-442 | 1-(1-{(2S)-3-[(6-chloronaphthalen-2-yl)s...)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of human thrombin after 10 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2010
Entry Details Article
PubMed
TargetCoagulation factor IX(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50317098(TAK-442 | 1-(1-{(2S)-3-[(6-chloronaphthalen-2-yl)s...)
Affinity DataIC50: 4.50E+3nMAssay Description:Inhibition of human factor 9a after 10 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2010
Entry Details Article
PubMed
TargetTissue-type plasminogen activator(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50317098(TAK-442 | 1-(1-{(2S)-3-[(6-chloronaphthalen-2-yl)s...)
Affinity DataIC50: 4.40E+4nMAssay Description:Inhibition of human tissue plasminogen activator after 5 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2010
Entry Details Article
PubMed
TargetPlasminogen(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50317098(TAK-442 | 1-(1-{(2S)-3-[(6-chloronaphthalen-2-yl)s...)
Affinity DataIC50: 6.00E+4nMAssay Description:Inhibition of human plasmin after 5 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2010
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50317098(TAK-442 | 1-(1-{(2S)-3-[(6-chloronaphthalen-2-yl)s...)
Affinity DataIC50: 2.20nMAssay Description:Inhibition of human factor 10a using S2222 as substrate after 10 mins by chromogenic assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2010
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetCoagulation factor X(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50317098(TAK-442 | 1-(1-{(2S)-3-[(6-chloronaphthalen-2-yl)s...)
Affinity DataIC50: 3.5nMAssay Description:Inhibition of factor 10aMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/2/2013
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetCoagulation factor X(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50317098(TAK-442 | 1-(1-{(2S)-3-[(6-chloronaphthalen-2-yl)s...)
Affinity DataKi:  1.80nMAssay Description:Inhibition of factor 10aMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/2/2013
Entry Details Article
PubMedPDB3D3D Structure (crystal)